TRIM24 and cancer: Moreover, the presence of some serum antibodies, such as anti-transcriptional intermediary factor 1 antibody (anti-TIF1-Ab), anti-p155, and antibodies against nuclear matrix protein (NXP)-2, anti-MJ, or anti-p140, are correlated with an increased risk of cancer [138,139,140].